888-794-0077 info@advancedtherapies.com
  • Twitter
  • Twitter
WuXi Advanced Therapies
  • Manufacturing
    • Phase
      • Commercial Manufacturing for Cell and Gene Therapies
      • Clinical Manufacturing for Cell and Gene Therapies
    • Platforms
      • AAV Vector Suspension
      • Lentiviral Vector
      • Closed Process CAR-T
    • Products
      • Plasmid Manufacturing
      • Viral Products
  • Testing
    • Analytical Development
    • Cell Line Characterization
    • Materials Characterization
    • Viral Clearance Validation
  • Discovery
  • Resources
    • Customer Toolbox
    • Knowlege Library
  • About Us
    • Our Story
    • Locations
    • News
    • Careers
  • Contact
    • Sales
    • Support
Select Page

By using this site, you agree to our updated Privacy and Cookie Policy.

Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201

Aug 22, 2023

– Agreement expansion facilitates preparation for commercial readiness for CABA-201, enabling treatment of patients in multiple planned clinical trials with separate parallel cohorts – – Partnership for CABA-201 builds on existing manufacturing agreement for clinical...

Categories

  • Events
  • News
  • Uncategorized
  • Terms of Use
  • Privacy Policy
Accelerating Progress and Time to Market
  • Twitter
© Copyright 2023 WuXi AppTec. All Rights Reserved.